Peptides Lack Reliable Safety Information, Watchdog Warns The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Oral Peptides: FAQs on Bioavailability, Safety, and Clinical Use AJMC The peptide problem: Hype is outrunning the evidence BPC 157 Kit Research for Tissue Repair Pathways Hydration Room BPC 157 and TB 500: Injury Healing Peptides Jonathan L. Glashow posted on the topic LinkedIn